Keywords: positive, new, data, aeterna, impavido, canada, released

Positive new data for AEterna's Impavido

Article | 11 August 2003

Print This

Canada's AEterna has released encouraging results from a Phase III trial examining the potential of its Impavido (miltefosine) for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in